The news: TrumpRx, the government’s online prescription drug marketplace, is adding more than 600 generic medications, allowing consumers to compare prices across pharmacies. The generics add to the 74 brand-name drugs offered on TrumpRx.

Digging into the details: The added generics include widely used medications for cholesterol, high blood pressure, diabetes, and other conditions. Through TrumpRx, consumers can compare prices across participating pharmacy partners, including Amazon Pharmacy, GoodRx, and Cost Plus Drugs. Users can also enter their location to see medication prices at nearby pharmacies.

Why it matters: Though TrumpRx doesn’t sell drugs directly and instead guides consumers to partner pharmacies to complete purchases, the platform is emerging as a valuable source to help users identify lower-cost medication options. TrumpRx has been visited more than 10 million times since its launch, according to the government.

TrumpRx is largely providing more pricing transparency versus delivering meaningful savings on generic drugs, which are already relatively inexpensive. Insured patients pay an average of $7 to $15 for generic medications, according to the Association for Accessible Medicines, while several pharmacies offer many generics for as little as $4 or $5 without insurance. Many Medicare members—who are among the highest users of prescription medications—pay as little as $2 for certain generics through participating Part D plans.

Implications for consumers and pharmacies: Generics (synthetic copies of chemical drugs) and biosimilars (highly similar versions of biologic drugs) account for 90% of all prescriptions filled but just 12% of prescription spending, per AAM. Real reductions in out-of-pocket drug spending will only come if consumers can access significantly lower prices for costly brand-name medications.

TrumpRx’s expanded drug offerings will steer consumers toward other pharmacy channels, driving business to smaller players like Amazon Pharmacy and Cost Plus Drugs. While these services have existed for years, many consumers likely didn’t understand when or how they could benefit from using them (i.e., when they could save money on a drug purchased at this pharmacy). This is a barrier TrumpRx’s marketplace could help remove by driving up awareness.

Pricing transparency will also intensify competition across the pharmacy landscape. More consumers will shop across pharmacy channels, giving some digital-first players greater exposure and forcing pharmacies to compete more aggressively on upfront, lower costs for prescription drugs.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.